Corporate Events

Shimadzu Corporation, Q1 2026 Earnings Call, Aug 07, 2025

Shimadzu Corporation announced that they will report Q1, 2026 results on Aug 07, 2025

Shimadzu Corporation expected to report Q1 2026 results on August 4, 2025. This event was calculated by S&P Global (Created on May 14, 2025).

Shimadzu Corporation, ¥ 4.00, Cash Dividend, Mar-28-2025

Shimadzu Corporation, Annual General Meeting, Jun 26, 2025, at 10:00 Tokyo Standard Time. Location: Main Hall at the Head Office 1, Nishinokyo Kuwabara-cho, Nakagyo-ku, Kyoto Japan Agenda: To consider the business report, consolidated financial statements for the 162nd fiscal year (April 1, 2024 - March 31, 2025) and results of audits of the consolidated financial statements by the accounting auditor and the audit & supervisory board; to consider the non-consolidated financial statements for the 162nd fiscal year (April 1, 2024 - March 31, 2025); to consider the appropriation of surplus; to consider the election of seven directors, members of the board; and to consider the election of one audit & supervisory board member.

Shimadzu Corporation announced commemorative cash dividend of JPY 4.00 per share for the 150th founding anniversary for year-end dividend for the fiscal year ended March 31, 2025, payable June 27, 2025.

Shimadzu Corporation provided dividend guidance for the fiscal year ending March 31, 2026. For the year, the company expects dividend of JPY 40.00 per share against JPY 36.00 per share paid a year ago.

Shimadzu Corporation provided Consolidated earnings guidance for the fiscal year ending March 31, 2026 . For the year, the company expected net sales by JPY 515,000 million, Operating profit of JPY 58,000 million, Profit attributable to owners of parent of JPY 45,000 million and Basic earnings per share of JPY 155.75 per share.

Shimadzu Corporation, Board Meeting, May 12, 2025. Agenda: To issue a dividend of surplus with a record date of March 31, 2025.

PeptiStar Inc. announced that it has entered into an investment agreement and will receive a round of funding on March 26, 2025. The transaction will include participation from new investor, Shimadzu Corporation.

The company closed its plan on March 5, 2025.

From January 1, 2025 to March 5, 2025, the company has repurchased 1,121,200 shares, representing 0.39% for ¥4,454.53 million. With this, the company has completed the repurchase of 5,803,000 shares, representing 1.98% for ¥24,999.8 million under the buyback announced on May 10, 2024.

Shimadzu Corporation announced that they will report fiscal year 2025 results on May 12, 2025

Basetwo Artificial Intelligence Inc. announced that it will receive $13,396,501 in funding on September 26, 2024. The company will issue simple agreement for future equity in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.

From October 1, 2024 to December 31, 2024, the company has repurchased 4,000,000 shares, representing 1.36% for ¥17,244 million. With this, the company has completed the repurchase of 4,681,800 shares, representing 1.59% for ¥20,545.28 million under the buyback announced on May 10, 2024.

Shimadzu Corporation, Q3 2025 Earnings Call, Feb 05, 2025

Shimadzu Corporation expected to report Fiscal Year 2025 results on May 13, 2025. This event was calculated by S&P Global (Created on April 4, 2025).

Shimadzu Corporation announced that they will report Q3, 2025 results on Feb 05, 2025

Shimadzu Corporation, ¥ 36.0, Cash Dividend, Mar-28-2025

Shimadzu Corporation expected to report Q3 2025 results on February 3, 2025. This event was calculated by S&P Global (Created on November 7, 2024).

Rege Nephro Co., Ltd. announced that it will receive ¥25,000 million in a round of funding led by new investor, DCI Partners Co., Ltd. on October 7, 2024. The transaction will include participation from mix of strategic investors including new investors, JIC Venture Growth Investments Co., Ltd., Nippon Venture Capital Co., Ltd., Tohoku University Venture Partners Co.,Ltd., Golden Asia Fund Venture Ltd., Mitsui Chemicals, Inc., Global Brain Corporation, Mitsubishi UFJ Capital Co., Ltd., Industrial Technology Investment Corporation, Shimadzu Corporation, SCREEN Holdings Co., Ltd., Chushin Venture Capital Co., Ltd., Senshu Ikeda Capital Co., Ltd., Toyo Seikan Group Holdings, Ltd., Asahi Kasei Corporation, QB Capital, LLC and i-Lab CVC1 Limited Liability Partnership, and returning investor, Kyoto University Innovation Capital Co., Ltd., JAFCO Group Co., Ltd., and other investors. On the same date, the company has received ¥22,500 million in its first tranche. The company has raised a total of ¥44,000 million in funding till date.

From July 1, 2024 to September 30, 2024, the company has repurchased 681,800 shares, representing 0.23% for ¥3,301.28 million. With this, the company has completed the repurchase of 681,800 shares, representing 0.23% for ¥3,301.28 million under the buyback announced on May 10, 2024.

Shimadzu Corporation announced that they will report first half, 2025 results on Nov 07, 2024

Shimadzu Corporation, Q2 2025 Earnings Call, Nov 08, 2024

Sustainability Management Briefing